Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19
Clinical trial NCT05541510 · TERMINATED
Trial details
- NCT number
- NCT05541510
- Sponsor
- Advagene Biopharma Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-08-05
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.